Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study

Autor: Koen Dudink, Klasiena Bouwman, Yanqing Chen, Samuel E DePrimo, Ernesto J Munoz-Elias, Pim Aarts, Renske Schappin, Edwin F Florencia, Bennie van Heeswijk, Lisette M Prens, Hessel H van der Zee, Errol P Prens, Kelsey R van Straalen, Barbara Horváth

Publikováno v: The British journal of dermatology, 188(5), 601-609. Wiley-Blackwell Publishing Ltd

Background The effectiveness of available biologics for the treatment of hidradenitis suppurativa (HS) is limited. Additional therapeutic options are needed. Objectives To investigate the efficacy and mode of action of guselkumab [an anti-interleukin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c4457f6eced82e3dbd65f4c82173954
https://pure.eur.nl/en/publications/b84d9b3c-e402-4832-8c4a-fdc9e1f2d91c

No Evident Systemic Terminal Complement Pathway Activation in Hidradenitis Suppurativa

Autor: Lisette M. Prens, Jeffrey Damman, Barbara Horváth, Marc A. Seelen, Hessel H. van der Zee, Kelsey R. van Straalen, Jon D. Laman, Christine B. Ardon, Errol P. Prens

Publikováno v: Experimental dermatology, 30, 47-47. Blackwell Publishing Ltd
Journal of Investigative Dermatology, 141(12), 2966-2969.e1. Nature Publishing Group
Journal of Investigative Dermatology, 141(12), 2966-2969.e1. ELSEVIER SCIENCE INC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd1d86fa70bc2b0179a987818e686f4
https://doi.org/10.1016/j.jid.2021.03.037

Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA)

Autor: Lisette M. Prens, R G Sibbald, Tetyana Rogalska, Boris Bauer, Melinda Gooderham, Mondana H. Ghias, Dennis D. Wong, Alain Brassard, Mia Sisic, Chelsea McLellen, Alexa B. Kimball, Errol P. Prens, Lauren K. Hoffman, Marc Bourcier, Marcus G. Tan, Jan P. Dutz, Falk G. Bechara, Raed Alhusayen, Angela Hou, Michelle A. Lowes, Vahid Djamei, Ali Mehdizadeh, Darya Kryzskaya, Iltefat H. Hamzavi, Afsaneh Alavi, Howard Hu, Charles Lynde, Ralph George, Mark G. Kirchhof, Maria del Carmen Liy Wong

Publikováno v: Experimental Dermatology, 27(1), 104-112. Wiley-Blackwell Publishing Ltd

Hidradenitis Suppurativa (HS) is a chronic debilitating skin condition that impairs the productivity and the quality of patients` lives. HS has recently drawn lots of attention among scholars to further expand their knowledge but it still loads with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0abe0f4f45cf2c98e201c51244344b6e
https://doi.org/10.1111/exd.13445

Adverse Reactions to Biologics in Psoriasis

Autor: Stephen J, Lockwood, Lisette M, Prens, Alexa B, Kimball

Publikováno v: Current problems in dermatology. 53

Psoriasis is a chronic autoimmune disease which affects millions of people worldwide. Not only can psoriasis itself be debilitating and significantly reduce an individual's quality of life, but it is also a risk factor for other systemic disorders, s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::35ecea840c371a1a0568b21b6714c405
https://pubmed.ncbi.nlm.nih.gov/29131033

Treatment of Hidradenitis Suppurativa

Autor: Stephen J. Lockwood, Lisette M. Prens, Martina L. Porter, Alexa B. Kimball

Publikováno v: Hidradenitis Suppurativa ISBN: 9783319505930

Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1α.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d0bf056b6fc38fd400d661fe4e2c37f7
https://doi.org/10.1007/978-3-319-50594-7_5